tirzepatide vs semaglutide weight loss vs. Semaglutide: Understanding Your Medication Options Tirzepatide vs Semaglutide: Which GLP-1

Using propensity-score matched analysis results showed that who were treated with a GLP-1 receptor agonist at 1 year VTE rates were 20% lower when compared to patients on a DDP-4 inhibitor

Boland ML, Laker RC, Mather K, et al

A whopping 94% feel that GLP-1s will negatively impact disadvantaged groups, who have less access to these drugs

Key strategies for minimizing the impact and severity of GI AEs associated with GLP-1 RA therapy include: Educational initiatives directed at both healthcare providers and patients Implementing different dose escalation schedules to improve patient adherence and overall outcomes in weight management treatment Understanding the pharmacokinetics of low dose initiation and gradual increase to the target dose to optimize treatment results Balancing the initial dosing with the achievement of target doses requires careful consideration and monitoring